BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1204 related articles for article (PubMed ID: 28105619)

  • 21. A novel predictive model based on preoperative blood neutrophil-to-lymphocyte ratio for survival prognosis in patients with gastric neuroendocrine neoplasms.
    Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
    Oncotarget; 2016 Jul; 7(27):42045-42058. PubMed ID: 27275541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of occult peritoneal metastases or positive cytology using CT in gastric cancer.
    Liu P; Ding P; Wu H; Wu J; Yang P; Tian Y; Guo H; Zhao Q
    Eur Radiol; 2023 Dec; 33(12):9275-9285. PubMed ID: 37414883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].
    Chen L; Zhang Y; Chen M; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Significance of Serum CA125, CA19-9, CA72-4, and Fibrinogen-to-Lymphocyte Ratio in Gastric Cancer With Peritoneal Dissemination.
    Huang C; Liu Z; Xiao L; Xia Y; Huang J; Luo H; Zong Z; Zhu Z
    Front Oncol; 2019; 9():1159. PubMed ID: 31750248
    [No Abstract]   [Full Text] [Related]  

  • 25. Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer.
    Pan YQ; Ruan YY; Peng JB; Han QY; Zhang X; Lin A; Yan WH
    Hum Immunol; 2016 Apr; 77(4):317-24. PubMed ID: 26788811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.
    Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J
    Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Value of Combination of Inflammatory and Tumor Markers in Resectable Gastric Cancer.
    Guo L; Wang Q; Chen K; Liu HP; Chen X
    J Gastrointest Surg; 2021 Oct; 25(10):2470-2483. PubMed ID: 33575904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of preoperative serum alanine aminotransferase and asparagine aminotransferase ratio on prognosis of patients with gastric cancer].
    Han BL; Wang YM; Xue YW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):65-70. PubMed ID: 31958933
    [No Abstract]   [Full Text] [Related]  

  • 29. Diagnostic laparoscopy, serum CA125, and peritoneal metastasis in gastric cancer.
    Fujimura T; Kinami S; Ninomiya I; Kitagawa H; Fushida S; Nishimura G; Kayahara M; Shimizu K; Ohta T; Miwa K
    Endoscopy; 2002 Jul; 34(7):569-74. PubMed ID: 12170412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined use of lysyl oxidase, carcino-embryonic antigen, and carbohydrate antigens improves the sensitivity of biomarkers in predicting lymph node metastasis and peritoneal metastasis in gastric cancer.
    Lai H; Jin Q; Lin Y; Mo X; Li B; He K; Chen J
    Tumour Biol; 2014 Oct; 35(10):10547-54. PubMed ID: 25060181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
    Song S; Liu H; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel immunological and nutritional-based prognostic index for gastric cancer.
    Sun KY; Xu JB; Chen SL; Yuan YJ; Wu H; Peng JJ; Chen CQ; Guo P; Hao YT; He YL
    World J Gastroenterol; 2015 May; 21(19):5961-71. PubMed ID: 26019461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nomogram analysis and external validation to predict the risk of lymph node metastasis in gastric cancer.
    Chen S; Nie RC; OuYang LY; Li YF; Xiang J; Zhou ZW; Chen Y; Peng JS
    Oncotarget; 2017 Feb; 8(7):11380-11388. PubMed ID: 28077786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
    Kim JH; Jun KH; Jung H; Park IS; Chin HM
    Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretreatment neutrophil-lymphocyte count ratio may associate with gastric cancer presence.
    Jiang Y; Xu H; Jiang H; Ding S; Zheng T
    Cancer Biomark; 2016 Mar; 16(4):523-8. PubMed ID: 27062567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nomogram based on tumor-associated neutrophil-to-lymphocyte ratio to predict survival of patients with gastric neuroendocrine neoplasms.
    Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
    World J Gastroenterol; 2017 Dec; 23(47):8376-8386. PubMed ID: 29307997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The neutrophil/lymphocyte ratio as a predictor of peritoneal metastasis during staging laparoscopy for advanced gastric cancer: a retrospective cohort analysis.
    Nakamura N; Kinami S; Fujii Y; Miura S; Fujita J; Kaida D; Tomita Y; Miyata T; Fujita H; Ueda N; Iida Y; Kosaka T
    World J Surg Oncol; 2019 Jun; 17(1):108. PubMed ID: 31238937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single and combined use of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and carcinoembryonic antigen in diagnosing gastric cancer.
    Wu Y; Jiang M; Qin Y; Lin F; Lai M
    Clin Chim Acta; 2018 Jun; 481():20-24. PubMed ID: 29476736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Nomogram Combining Neutrophil-to-Lymphocyte Ratio and D-Dimer Predicts Chemosensitivity of Oxaliplatin-Based First-Line Chemotherapy in Patients with Unresectable Advanced Gastric Cancer.
    Shen H; Wu S; Su R; Chen Y; He Y
    Technol Cancer Res Treat; 2022; 21():15330338221112741. PubMed ID: 35880288
    [No Abstract]   [Full Text] [Related]  

  • 40. Novel prognostic indicator combining inflammatory indicators and tumor markers for gastric cancer.
    Yu L; Jiang R; Chen W; Liu Y; Wang G; Gong X; Wang Y
    World J Surg Oncol; 2023 Feb; 21(1):50. PubMed ID: 36803398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.